Dr. Ting He is a seasoned expert in gene therapy, with experience spanning preclinical research and pharmaceutical development for AAV-based therapeutics. She holds a Ph.D. in Neuroscience from the University of Oklahoma Health Sciences Center. Currently, she serves as an Associate Director at Ultragenyx Pharmaceutical, where she leads the development of cell-based assays and works cross-functionally with the Pharmaceutical Development and CMC teams to drive pipeline programs forward.